Global Key SolutionsGKS
Guidance Documents/Guidance-Document/Mpox: Development of Drugs and Biological Products; Guidance for Industry

Mpox: Development of Drugs and Biological Products; Guidance for Industry

Detailed guidance document from FDA and regulatory agencies.

Document Details

Guidance Document

January 19, 2023

January 23, 2023

Center for Drug Evaluation and Research

ef1c9a82-c229-49ef-a357-d9947fb4dcdb

Related Documents

Clinical Pharmacology Considerations for Peptide Drug Products

Guidance DocumentDecember 14, 2023Center for Drug Evaluation and Research
View Details →

Psychedelic Drugs: Considerations for Clinical Investigations

Guidance DocumentJune 23, 2023Center for Drug Evaluation and Research
View Details →

Development of Local Anesthetic Drug Products With Prolonged Duration of Effect

Guidance DocumentMarch 15, 2023Center for Drug Evaluation and Research
View Details →

Quick Actions

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
[email protected]
Quick Links
KeyPedia™ Lite
Legal & Ethics
©2026, Global Key Solutions All rights reserved.